Literature DB >> 24238922

Innate immune mechanisms in vitiligo: danger from within.

Jillian M Richmond1, Michael L Frisoli, John E Harris.   

Abstract

Vitiligo is an autoimmune disease of the skin in which melanocytes are destroyed by antigen-specific T cells, resulting in patchy depigmentation. Although adaptive immunity plays a clear role in disease progression, initiating factors are largely unknown. Many studies report that cellular stress pathways are dysregulated in melanocytes from vitiligo patients, suggesting that melanocyte-intrinsic defects participate in disease pathogenesis. Recent studies reveal that melanocyte stress generates damage-associated molecular patterns that activate innate immunity, thus connecting stress to organ-specific inflammation. Genetic studies in vitiligo support a role for stress, innate immunity, and adaptive mechanisms. Here, we discuss advances in the field that highlight how cellular stress, endogenous danger signals, and innate immune activation promote the onset of vitiligo.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24238922      PMCID: PMC3935321          DOI: 10.1016/j.coi.2013.10.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  65 in total

1.  Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay.

Authors:  E H Kemp; E A Waterman; D J Gawkrodger; P F Watson; A P Weetman
Journal:  Br J Dermatol       Date:  1998-11       Impact factor: 9.302

2.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

3.  miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells.

Authors:  Sivasubramani Thulasingam; Chandirasegaran Massilamany; Arunakumar Gangaplara; Hongjiu Dai; Shahlo Yarbaeva; Sakthivel Subramaniam; Jean-Jack Riethoven; James Eudy; Marjorie Lou; Jay Reddy
Journal:  Mol Cell Biochem       Date:  2011-02-25       Impact factor: 3.396

4.  Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.

Authors:  B Palermo; R Campanelli; S Garbelli; S Mantovani; E Lantelme; V Brazzelli; M Ardigó; G Borroni; M Martinetti; C Badulli; A Necker; C Giachino
Journal:  J Invest Dermatol       Date:  2001-08       Impact factor: 8.551

5.  In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects.

Authors:  N Puri; M Mojamdar; A Ramaiah
Journal:  J Invest Dermatol       Date:  1987-04       Impact factor: 8.551

Review 6.  Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation.

Authors:  D L Eizirik; M Miani; A K Cardozo
Journal:  Diabetologia       Date:  2012-11-07       Impact factor: 10.122

7.  Stress signals activate natural killer cells.

Authors:  Eric O Long; Sumati Rajagopalan
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

8.  Reduced skin homing by functional Treg in vitiligo.

Authors:  Jared Klarquist; Cecele J Denman; Claudia Hernandez; Derek A Wainwright; Derek J Wainwright; Faith M Strickland; Andreas Overbeck; Shikar Mehrotra; Michael I Nishimura; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2010-02-19       Impact factor: 4.693

9.  Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.

Authors:  Anna Wańkowicz-Kalińska; René M J G J van den Wijngaard; Bert J Tigges; Wiete Westerhof; Graham S Ogg; Vincenzo Cerundolo; Walter J Storkus; Pranab K Das
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

10.  Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.

Authors:  Richard Yu; Raewyn Broady; Yuanshen Huang; Yang Wang; Jie Yu; Min Gao; Megan Levings; Shencai Wei; Shengquan Zhang; Aie Xu; Mingwan Su; Jan Dutz; Xuejun Zhang; Youwen Zhou
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more
  41 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  A New View of Vitiligo: Looking at Normal-Appearing Skin.

Authors:  Mauro Picardo; Emanuela Bastonini
Journal:  J Invest Dermatol       Date:  2015-07       Impact factor: 8.551

Review 3.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 4.  Chemical-Induced Vitiligo.

Authors:  John E Harris
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

Review 5.  Vitiligo Pathogenesis and Emerging Treatments.

Authors:  Mehdi Rashighi; John E Harris
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

6.  MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Authors:  Anupama Sahoo; Bongyong Lee; Katia Boniface; Julien Seneschal; Sanjaya K Sahoo; Tatsuya Seki; Chunyan Wang; Soumen Das; Xianlin Han; Michael Steppie; Sudipta Seal; Alain Taieb; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2017-05-11       Impact factor: 8.551

7.  Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Authors:  Roselyne Y Wagner; Flavie Luciani; Muriel Cario-André; Alain Rubod; Valérie Petit; Laila Benzekri; Khaled Ezzedine; Sébastien Lepreux; Eirikur Steingrimsson; A Taieb; Yvon Gauthier; Lionel Larue; Véronique Delmas
Journal:  J Invest Dermatol       Date:  2015-01-29       Impact factor: 8.551

Review 8.  The Role of Memory CD8+ T Cells in Vitiligo.

Authors:  Rebecca L Riding; John E Harris
Journal:  J Immunol       Date:  2019-07-01       Impact factor: 5.422

Review 9.  Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.

Authors:  John E Harris
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

Review 10.  Understanding autoimmunity of vitiligo and alopecia areata.

Authors:  Jillian F Rork; Mehdi Rashighi; John E Harris
Journal:  Curr Opin Pediatr       Date:  2016-08       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.